Pembrolizumab Shows Promise for Some Hard-to-Treat Rare Cancers
Online First/Online Only: Posts,
A study conducted by researchers at The University of Texas MD Anderson Cancer Center demonstrated acceptable toxicity and anti-t…
A study conducted by researchers at The University of Texas MD Anderson Cancer Center demonstrated acceptable toxicity and anti-t…
Open-label Phase II study at MD Anderson reports on four cancer…